GlassScriptPhysician profile
Brett Mcgowan
NPI 1023434347
$5,068.45
in general payments reported to CMS, 2019-2025
14 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,207 · 2022: $145 · 2023: $284 · 2024: $166 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $626 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $625.90 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,332.12 | 2021-2022 | |
| Astellas Pharma US INC | $208.58 | 2023-2024 | Veozah |
| Organon LLC | $117.67 | 2023-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $111.91 | 2022-2025 | |
| Amgen INC. | $64.59 | 2023-2024 | Prolia, Evenity, Repatha |
| Mayne Pharma Commercial LLC | $52.28 | 2025 | |
| Octapharma USA, INC. | $48.09 | 2025 | Fibryga |
| Exeltis, USA INC. | $30.50 | 2023 | Slynd |
| Sage Therapeutics, LLC | $20.25 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $20.25 | 2025 | Qelbree |
| Hologic Sales and Service, LLC | $18.13 | 2025 | Novasure |
| Lundbeck LLC | $16.78 | 2024 | Rexulti |
| Abbvie INC. | $14.11 | 2024 | |
| Exact Sciences Corporation | $13.19 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Mcgowan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.